AOD-9604 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
AOD-9604 (Fragment 177-191 of Human Growth Hormone (modified)) is a Lipolytic peptide, GH fragment analog researched for fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation. Common dosages range from 250-1000 mcg daily administered once daily, ideally morning fasted. Below are the most frequently asked questions.
Frequently Asked Questions About AOD-9604
What is AOD-9604?
AOD-9604 (Fragment 177-191 of Human Growth Hormone (modified)) is a Lipolytic peptide, GH fragment analog. Synthetic analog of human GH fragment 177-191, engineered to selectively activate lipolysis without systemic GH effects. It is researched for fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation.
What is the recommended AOD-9604 dosage?
Common dosages range from 250-1000 mcg daily, administered once daily, ideally morning fasted via subcutaneous injection. Cycles typically run 12-24 weeks.
What are the side effects of AOD-9604?
Well-tolerated across 900+ participants in clinical trials. Minimal adverse effects — potential mild headache, dizziness, or injection site reactions. One of the safest peptides in terms of documented human tolerability.
Is AOD-9604 legal?
Not FDA-approved. Development discontinued 2007. Available as research chemical.
What is the half-life of AOD-9604?
The half-life of AOD-9604 is not established, which determines the once daily, ideally morning fasted dosing schedule.
How do you reconstitute AOD-9604?
Add bacteriostatic water to the lyophilized AOD-9604 vial. Let the water run down the side — never spray on the powder. Swirl gently. Use our peptide calculator for exact amounts.
Can you stack AOD-9604 with other peptides?
Pairs with CJC-1295/Ipamorelin for enhanced body composition (AOD handles fat loss while GH peptides handle lean mass). Also complements fasting and HIIT training protocols.
Where can you buy AOD-9604?
AOD-9604 is available as a research chemical from vetted suppliers with third-party COA testing.
How long does it take AOD-9604 to work?
Initial effects may be noticed within 1-2 weeks, with more significant results typically appearing by weeks 4-8 of a 12-24 weeks cycle.
What makes AOD-9604 unique?
The only GH fragment that selectively targets fat loss without any of growth hormone's effects on blood sugar, insulin, or IGF-1 — making it metabolically clean. The catch is that human efficacy was modest compared to impressive animal data.
Complete Guide
AOD-9604: The Fat Loss Peptide Fragment
Related Reading
- AOD-9604 Dosage Guide
- AOD-9604 Benefits
- AOD-9604 Side Effects
- AOD-9604 Stacking Guide
- AOD-9604 Cycle Guide
- AOD-9604 Research
Calculate Your AOD-9604 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for AOD-9604.
Open Calculator →Research-Grade Sourcing
If you're going to research AOD-9604, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is AOD-9604?
AOD-9604 (Fragment 177-191 of Human Growth Hormone (modified)) is a Lipolytic peptide, GH fragment analog. Synthetic analog of human GH fragment 177-191, engineered to selectively activate lipolysis without systemic GH effects. It is researched for fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation.
What is the recommended AOD-9604 dosage?
Common dosages: 250-1000 mcg daily administered once daily, ideally morning fasted via subcutaneous injection. Cycle length: 12-24 weeks. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of AOD-9604?
Well-tolerated across 900+ participants in clinical trials. Minimal adverse effects — potential mild headache, dizziness, or injection site reactions. One of the safest peptides in terms of documented human tolerability.
Is AOD-9604 safe?
AOD-9604 has shown a favorable safety profile in research. Not FDA-approved. Development discontinued 2007. Available as research chemical. All research should follow appropriate safety protocols.